In the treatment of ASS1‐deficient cutaneous melanoma, uveal melanoma, and malignant pleural mesothelioma, ADI‐PEG 20 was well tolerated and demonstrated antitumor activity.9, 10, 23, 24. The gene discussed is ASS1; the disease is cutaneous melanoma.